Trial intelligence / Profile preview

Ramelteon in Sleep Disturbed Alzheimer's Disease

NCT00325728Phase 2Completed

Sponsor
Takeda
Start
Mar 2006
Primary completion
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ramelteon in Insomnia, sponsored by Takeda. Started Mar 2006; status: completed.

02

Drugs

ramelteon
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT00325728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00325728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call